Procarbazine
Pediatric
Memorial Sloan Kettering Cancer CenterSmall moleculePhase 2Dormant
B
57/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 42/ 100
- Competitive Position
- 95/ 100
Competitive context
2 Active assets in the Pediatric cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Berotralstat BioCryst Pharmaceuticals | Phase 3 | B |
Cyclophosphamide Memorial Sloan Kettering Cancer Center | Phase 2 | B |
PREDNISONE TABLETS Memorial Sloan Kettering Cancer Center | Phase 2 | B |
(+)-VINCRISTINE Memorial Sloan Kettering Cancer Center | Phase 2 | B |
VINBLASTINE Memorial Sloan Kettering Cancer Center | Phase 2 | B |
View all 9 →
Same molecule, other indications
Procarbazine is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →